Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 201–300 of 911
Kozono, D., Li, J., Nitta, M., Sampetrean, O., Gonda, D. D., Kushwaha, D. S., Merzon, D., Ramakrishnan, V., Zhu, S., Zhu, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501967112 · Cited by 88
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 96
DeMasters, G. A., Di, X. M., Newsham, I., Shiu, R. P. C., & Gewirtz, D. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0316 · Cited by 85
Shin, J.-Y., Choi, Y. Y., Jeon, H.-S., Hwang, J.-H., Kim, S.-A., Kang, J.-H., Chang, Y.-S., Jacobs, D. R., Park, J. Y., & Lee, D.-H. (2010) · Mutagenesis · doi:10.1093/mutage/geq035 · Cited by 85
Ducrest, A., Amacker, M., Mathieu, Y., Cuthbert, A. P., Trott, D. A., Newbold, R. F., Nabholz, M., & Lingner, J. (2001) · PubMed · Cited by 101
Self-citationUnusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines
Guilleret, I., & Benhattar, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.137 · Cited by 85
Casciano, J. C., Perry, C. E., Cohen-Nowak, A. J., Miller, K. D., Voorde, J. V., Zhang, Q., Chalmers, S., Sandison, M. E., Liu, Q., Hedley, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0711-3 · Cited by 87
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells
Nemoto, K., Kondo, Y., Himeno, S., Suzuki, Y., Hara, S., Akimoto, M., & Imura, N. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00334-2 · Cited by 84
Telomerase regulation at the crossroads of cell fate
Ćukušić, A., Vidaček, N. Š., Sopta, M., & Rubelj, I. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167812 · Cited by 93
Terrin, L., Col, J. D., Rampazzo, E., Zancai, P., Pedrotti, M., Ammirabile, G., Bergamin, S., Rizzo, S., Dolcetti, R., & Rossi, A. D. (2008) · Journal of Virology · doi:10.1128/jvi.00321-08 · Cited by 88
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene
Zhu, J., Zhao, Y., & Wang, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0014-1 · Cited by 81
Ouchi, H., Ishiguro, H., IKEDA, N., Hori, M., Kubota, Y., & Uemura, H. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2004.00973.x · Cited by 88
Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Reddel, R. R. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630101047 · Cited by 97
miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively
Song, G., Wang, R., Guo, J., Liu, X., Wang, F., Qi, Y., Wan, H., Liu, M., Li, X., & Tang, H. (2015) · Scientific Reports · doi:10.1038/srep15793 · Cited by 87
Lee, J. H., & Chung, I. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.026 · Cited by 81
MUC1-C drives MYC in multiple myeloma
Tagde, A., Rajabi, H. N., Bouillez, A., Alam, M., Gali, R. R., Bailey, S. T., Tai, Y., Hideshima, T., Anderson, K. C., Avigan, D., et al. (2016) · Blood · doi:10.1182/blood-2015-07-659151 · Cited by 84
Leem, S., Londoño‐Vallejo, A., Kim, J.-H., Bui, H., Tubacher, E., Solomon, G. G., Park, J., Horikawa, I., Kouprina, N., Barrett, J. C., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205122 · Cited by 85
Suenaga, M., Soda, H., Oka, M., Yamaguchi, A., Nakatomi, K., Shiozawa, K., Kawabata, S., Kasai, T., Yamada, Y., Kamihira, S., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.10082 · Cited by 81
Katzenellenbogen, R. A., Egelkrout, E. M., Vliet-Gregg, P., Gewin, L. C., Gafken, P. R., & Galloway, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.02007-06 · Cited by 78
Bayne, S., Jones, M. E. E., Li, H., Pinto, A. R., Simpson, E. R., & Liu, J. (2008) · Cell Research · doi:10.1038/cr.2008.291 · Cited by 85
Cevik, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.311 · Cited by 71
Park, S.-E., Yoo, H., Jin, C., Hong, S. H., Lee, Y.-W., Kim, B. W., Lee, S. H., Kim, W., Cho, C.-K., & Choi, Y. H. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.04.014 · Cited by 76
Zhang, Y., Chen, F., Fonseca, N. A., He, Y., Fujita, M., Nakagawa, H., Zhang, Z., Brāzma, A., PCAWG Transcriptome Working Group, Amin, S. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13885-w · Cited by 81
Self-citationLu, J., Meng, L.-H., Shankavaram, U. T., Zhu, C.-H., Tong, L.-J., Chen, G., Lin, L.-P., Weinstein, J. N., & Ding, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.016 · Cited by 75
Li, C., Li, C., Lin, Y., Ho, M., Chen, D., Chen, P., & Yeh, S. (2018) · Hepatology · doi:10.1002/hep.30201 · Cited by 75
Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs
Winkler, T., Hong, S. G., Decker, J. E., Morgan, M. J., Wu, C., Hughes, W. M., Yang, Y., Wangsa, D., Padilla-Nash, H. M., Ried, T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67146 · Cited by 72
Akiyama, M., Yamada, O., Kanda, N., Akita, S., Kawano, T., Ohno, T., Mizoguchi, H., Eto, Y., Anderson, K. C., & Yamada, H. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00838-2 · Cited by 82
DNA Repair at Telomeres: Keeping the Ends Intact
Webb, C. J., Wu, Y., & Zakian, V. A. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012666 · Cited by 79
Duangmano, S., Dakeng, S., Jiratchariyakul, W., Suksamrarn, A., Smith, D. R., & Patmasiriwat, P. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11125323 · Cited by 77
A Novel c-Myc- responsive Gene, JPO1, Participates in Neoplastic Transformation
Prescott, J. E., Osthus, R. C., Lee, L. A., Lewis, B. C., Shim, H., Barrett, J. F., Guo, Q. M., Hawkins, A. L., Griffin, C. A., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107357200 · Cited by 72
Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells
Kim, M.-O., Moon, D., Choi, Y. H., Shin, D. Y., Kang, H. S., Choi, B. T., Lee, J.-D., Li, W., & Kim, G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.010 · Cited by 74
Chang, J. T., Lu, Y.-C., Chen, Y., Tseng, C.-P., Chen, Y.-L., Fang, C.-W., & Cheng, A.-J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603008 · Cited by 71
Oh, S., Song, Y., Kim, U.-J., Yim, J., & Kim, T. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1366 · Cited by 80
Telomeres and Telomerase in the Development of Liver Cancer
der Stroth, L. I., Tharehalli, U., Güneş, Ç., & Lechel, A. (2020) · Cancers · doi:10.3390/cancers12082048 · Cited by 77
Gabet, A., Accardi, R., Bellopede, A., Popp, S., Boukamp, P., Sylla, B. S., Londoño‐Vallejo, A., & Tommasino, M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8389com · Cited by 75
Deng, W., Cheung, S. T., Tsao, S. W., Wang, X. M., & Tiwari, A. F. Y. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.017 · Cited by 65
Bajaj, B. G., Murakami, M., Cai, Q., Verma, S. C., Lan, K., & Robertson, E. S. (2008) · Journal of Virology · doi:10.1128/jvi.02500-07 · Cited by 76
Elkady, A. I., Abuzinadah, O. A., Baeshen, N. A., & Rahmy, T. R. (2012) · BioMed Research International · doi:10.1155/2012/614356 · Cited by 83
RetractedCurrent Insights to Regulation and Role of Telomerase in Human Diseases
Ozturk, M., Li, Y., & Tergaonkar, V. (2017) · Antioxidants · doi:10.3390/antiox6010017 · Cited by 67
hTERT Gene Amplification and Increased mRNA Expression in Central Nervous System Embryonal Tumors
Fan, X., Wang, Y., Kratz, J. E., Brat, D. J., Robitaille, Y., Moghrabi, A., Perlman, E. J., Dang, C. V., Burger, P. C., & Eberhart, C. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64311-8 · Cited by 76
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes
Xu, M., Luo, W., Elzi, D. J., Grandori, C., & Galloway, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01969-07 · Cited by 68
Self-citationArsenic induces telomerase expression and maintains telomere length in human cord blood cells
Ferrario, D., Collotta, A., Carfì, M., Bowe, G., Vahter, M., Härtung, T., & Gribaldo, L. (2009) · Toxicology · doi:10.1016/j.tox.2009.03.019 · Cited by 72
Liu, X., Dakic, A., Chen, R., Disbrow, G. L., Zhang, Y., Dai, Y., & Schlegel, R. (2008) · Journal of Virology · doi:10.1128/jvi.01318-08 · Cited by 68
B chromosomes: from cytogenetics to systems biology
Valente, G. T., Nakajima, R. T., Fantinatti, B. E. A., Marques, D. F., Almeida, R. O., Simões, R. P., & Martins, C. (2016) · Chromosoma · doi:10.1007/s00412-016-0613-6 · Cited by 68
Wang, S., & Zhu, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209544200 · Cited by 72
Johnatty, S. E., Beesley, J., Chen, X., MacGregor, S., Duffy, D. L., Spurdle, A. B., DeFazio, A., Gava, N., Webb, P. M., Australian Ovarian Cancer Study Group, et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001016 · Cited by 67
Katzenellenbogen, R. A., Vliet-Gregg, P. A., Xu, M., & Galloway, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.02556-08 · Cited by 67
Yu, J., Guo, Q., You, Q., Lin, S., Zhao, L., Gu, H.-Y., Zhang, H.-W., Tan, Z., & Wang, X. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0177-2 · Cited by 66
Luan, F., Liu, H., Gao, L., Liu, J., Sun, Z., Ju, Y., Hou, N., Guo, C. H., Liang, X., Zhang, L., et al. (2009) · Gut · doi:10.1136/gut.2008.174029 · Cited by 66
Krismann, M., Müller, K., Jaworska, M., & Johnen, G. (2002) · The Journal of Pathology · doi:10.1002/path.1128 · Cited by 66
Moon, D., Kang, S.-H., Kim, K.-C., Kim, M.-O., Choi, Y. H., & Kim, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.009 · Cited by 66
Fotouhi, O., Fahmideh, M. A., Kjellman, M., Sulaiman, L. R., Höög, A., Zedenius, J., Hashemi, J., & Larsson, C. (2014) · Epigenetics · doi:10.4161/epi.28936 · Cited by 70
Sasaki, M., Oh, B. R., Dharia, A., Fujimoto, S., & Dahiya, R. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200010)29:2<59::aid-mc2>3.0.co;2-6 · Cited by 69
Taheri, M. N., Ghafouri‐Fard, S., Najafi, S., Kallenbach, J., Keramatfar, E., Roozbahani, G. A., Horestani, M. H., Hussen, B. M., & Baniahmad, A. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02678-9 · Cited by 66
Panda, D., Debnath, M., Mandal, S., Bessi, I., Schwalbe, H., & Dash, J. (2015) · Scientific Reports · doi:10.1038/srep13183 · Cited by 63
Zhou, X. Z., Huang, P., Shi, R., Lee, T. H., Lu, G. H., Zhang, Z., Bronson, R. T., & Lu, K. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43452 · Cited by 64
Vascular Actions of Angiotensin 1–7 in the Human Microcirculation: Novel Role for Telomerase
Durand, M. J., Zinkevich, N. S., Riedel, M. J., Gutterman, D. D., Nasci, V. L., Salato, V. K., Hijjawi, J. B., Reuben, C. F., North, P. E., & Beyer, A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307518 · Cited by 65
Direct Activation of HSP90A Transcription by c-Myc Contributes to c-Myc-induced Transformation
Teng, S., Chen, Y., Su, Y., Chou, P.-C., Chiang, Y.-C., Tseng, S., & Wu, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308842200 · Cited by 66
Self-citationLiao, C.-H., Hsiao, Y., Hsu, C., Lin, M., Wang, J. C., Huang, Y., & Ko, J. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20161 · Cited by 64
Telomere dysfunction and its role in haematological cancer
Jones, C. H., Pepper, C. J., & Baird, D. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09022.x · Cited by 66
STK38 is a critical upstream regulator of MYC’s oncogenic activity in human B-cell lymphoma
Bisikirska, B. C., Adam, S. J., Alvarez, M. J., Rajbhandari, P., Cox, R., Lefèbvre, C., Wang, K., Rieckhof, G. E., Felsher, D. W., & Califano, A. (2012) · Oncogene · doi:10.1038/onc.2012.543 · Cited by 64
Genomic Aberrations and Cellular Heterogeneity in SV40-Immortalized Human Corneal Epithelial Cells
Yamasaki, K., Kawasaki, S., Young, R. D., Fukuoka, H., Tanioka, H., Nakatsukasa, M., Quantock, A. J., & Kinoshita, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2239 · Cited by 65
MYC drives overexpression of telomerase RNA ( hTR / TERC ) in prostate cancer
Valle, J. A. B.-D., Zheng, Q., Esopi, D., Rubenstein, M., Hubbard, G. K., Moncaliano, M. C., Hruszkewycz, A. M., Vaghasia, A. M., Yegnasubramanian, S., Wheelan, S. J., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4980 · Cited by 66
Telomerase is regulated by protein kinase C-ζ in human nasopharyngeal cancer cells
Yu, C.-C., Shi-Ching, L. O., & Wang, T. V. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550459 · Cited by 66
α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
Sengupta, S., Weeraratne, S. D., Sun, H., Phallen, J. A., Rallapalli, S., Teider, N., Kosaras, B., Amani, V. M., Francois, J. P., Tang, Y., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1205-7 · Cited by 67
The Molecular Mechanism of Induced Pluripotency: A Two-Stage Switch
Scheper, W., & Copray, S. C. V. M. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9077-x · Cited by 67
PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein
Gao, Q., Kumar, A., Srinivasan, S., Singh, L., Mukai, H., Ono, Y., Wazer, D. E., & Band, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14824 · Cited by 61
Dual roles of c-Myc in the regulation of hTERT gene
Zhao, Y., Cheng, D., Wang, S., & Zhu, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku721 · Cited by 66
Molecular regulation of telomerase activity in aging
Nicholls, C., Li, H., Wang, J.-Q., & Liu, J.-P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1093-3 · Cited by 53
Tang, B., Xie, R., Qin, Y., Xiao, Y., Yong, X., Zheng, L., Dong, H. F., & Yang, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6575 · Cited by 62
Aubert, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00004-9 · Cited by 62
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
Agarwal, N., Rinaldetti, S. L., Cheikh, B. B., Zhou, Q., Hass, E. P., Jones, R. T., Joshi, M., LaBarbera, D. V., Knott, S., Cech, T. R., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102423118 · Cited by 58
c-myc Suppression in Burkitt's Lymphoma Cells
Simonsson, T., & Arsenian‐Henriksson, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6096 · Cited by 58
Campbell, L. J., Fidler, C., Eagleton, H., Peniket, A., Kušec, R., Gal, S., Littlewood, T. J., Wainscoat, J. S., & Boultwood, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404141 · Cited by 61
The PTEN regulator DJ‐1 is associated with hTERT expression in clear cell renal cell carcinoma
Sitaram, R. T., Cairney, C. J., Grabowski, P., Keith, W. N., Hallberg, B., Ljungberg, B., & Roos, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24335 · Cited by 59
Duss, S., André, S., Nicoulaz, A.-L., Fiche, M., Bonnefoi, H. R., Brisken, C., & Iggo, R. D. (2007) · Breast Cancer Research · doi:10.1186/bcr1734 · Cited by 63
Eldholm, V., Haugen, A., & Zienolddiny, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28570 · Cited by 56
Human telomerase expression regulation
Machnik, M., Wojtyla, A., & Rubiś, B. (2011) · Biochemistry and Cell Biology · doi:10.1139/o11-037 · Cited by 62
Functions of Myc:Max in the Control of Cell Proliferation and Tumorigenesis
Hurlin, P. J., & Dezfouli, S. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)38004-6 · Cited by 59
Chang, J. T., Yang, H., Wang, T. V., & Cheng, A. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20129 · Cited by 56
Liao, C.-H., Hsiao, Y., Sheu, G., Chang, J. T., Wang, P.-H., Wu, M., Shieh, G.-J., Hsu, C., & Ko, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.025 · Cited by 57
Kyrgidis, Α., Tzellos, T., & Triaridis, S. (2010) · Journal of Carcinogenesis · doi:10.4103/1477-3163.62141 · Cited by 59
Ohba, S., Mukherjee, J., Johannessen, T.-C., Mancini, A., Chow, T. T., Wood, M., Jones, L., Mazor, T., Marshall, R. E., Viswanath, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0696 · Cited by 56
Ghareghomi, S., Ahmadian, S., Zarghami, N., & Kahroba, H. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.015 · Cited by 55
Cyclin a but not cyclin D1 is essential for c‐myc‐modulated cell‐cycle progression
Qi, Y., Tu, Y., Yang, D., Chen, Q., Xiao, J. H., Chen, Y., Fu, J., Xiao, X., & Zhou, Z. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20816 · Cited by 61
Lee, S., Kim, J., Lee, H., Cho, Y.-S., Oh, S.-H., Kim, Y.-J., Jung, C.-H., Zhang, W., & Lee, J.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206133 · Cited by 57
Genetics of cellular senescence
Tominaga, K., Olgun, A., Smith, J. R., & Pereira‐Smith, O. M. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00030-1 · Cited by 57
A Novel Conditionally Replicative Adenovirus Vector Targeting Telomerase-Positive Tumor Cells
Huang, Q., Zhang, X., Wang, H., Yan, B., Kirkpatrick, J. P., Dewhrist, M. W., & Li, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0122 · Cited by 61
Liau, J., Tsai, J., Yang, C., Lee, J., Liang, C., Hsu, H.-H., & Jeng, Y. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.05.019 · Cited by 56
Chi, J.-Q., Teng, M., Yu, Z., Xu, H. M., Su, J.-W., Zhao, P., Xing, G., Liang, H.-D., Deng, R., Qu, L., et al. (2014) · Virology · doi:10.1016/j.virol.2014.11.027 · Cited by 55
Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis
Chen, J., Wei, Y., Chen, X., Jiao, J., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.14236 · Cited by 52
Lamy, E., Herz, C., Lutz‐Bonengel, S., Hertrampf, A., Márton, M.-R., & Mersch‐Sundermann, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053240 · Cited by 54
Kirkpatrick, K. L., Ogunkolade, W., Elkak, A. E., Bustin, S., Jenkins, P., Ghilchick, M., Newbold, R. F., & Mokbel, K. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021849217054 · Cited by 53
Telomerase as a useful target in cancer fighting—the breast cancer case
Hołysz, H., Lipińska, N., Paszel-Jaworska, A., & Rubiś, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-0757-4 · Cited by 56
Niu, C., & Yip, H. K.-F. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318222b97b · Cited by 53
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Amen, A. M., Fellmann, C., Soczek, K. M., Ren, S. M., Lew, R. J., Knott, G. J., Park, J. E., McKinney, A., Mancini, A., Doudna, J. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008772118 · Cited by 55
Hepatitis C Virus Core Protein Is Necessary for the Maintenance of Immortalized Human Hepatocytes
Basu, A., Meyer, K., Ray, R. B., & Ray, R. (2002) · Virology · doi:10.1006/viro.2002.1460 · Cited by 57
Niccoli, S., Abraham, S., Richard, C., & Zehbe, I. (2012) · Journal of Virology · doi:10.1128/jvi.01512-12 · Cited by 62
Shalaby, T., von Bueren, A. O., Hürlimann, M.-L., Fiaschetti, G., Castelletti, D., Tera, M., Nagasawa, K., Arcaro, A., Jelesarov, I., Shin‐ya, K., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0586 · Cited by 52
Gay‐Bellile, M., Véronèse, L., Combes, P., Eymard-Pierre, É., Kwiatkowski, F., Dauplat, M.-M., Cayre, A., Privat, M., Abrial, C., Bignon, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20560 · Cited by 56
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.